33^rd Global Experts Meeting on Cancer Science & Therapy April 29-30, 2019 Seoul, South Korea

Jijo Francis is doing his Post Graduation (M.Sc.) in Zoology in Sacred Heart College (Autonomous), Cochin, Kerala, India.

Anticancer Properties of the Foliose Lichen, Heterodermia diademata (Taylor) Awasthi against Breast Cancer Cell Lines

Wen Xiu Ren received Ph.D. from Kyungpook National University in 2009. He then joined Prof. Jong Seung Kim’s laboratory at Korea University as a postdoctoral fellow. Currently he moved to Department of Medical Imageology at Southwest Medical University and Department of Radiology at the Affiliated Hospital of Southwest Medical University as an Associate Professor. His research focuses on the design, synthesis, and biomedical applications of molecular contrast agents, fluorescent chemosensors, and anticancer targeting theranostics.

His research focuses on the design, synthesis, and biomedical applications of molecular contrast agents, fluorescent chemosensors, and anticancer targeting theranostics.

In 2006, Dr. Ahmed M Malki earned his PhD in Biochemistry in the field of molecular oncology from Ohio University in USA. Right after, he held postdoctoral position at the University of California Berkeley in 2007, USA. Dr Malki currently Associate Dean for Academic Affairs at college of health Sciences at Qatar University. Dr. Malki also received the Best Research Award, Global Breast Cancer conference, 2011, Seoul, South Korea, Alexandria University Award for Scientific encouragement in 2012, best poster award at the Annual research Day 2014 and the best poster award for faculty at QU research forum in 2016 and QU health retreat 2019. Dr Malki has several peer reviewed international publications in cancer research, he is currently serving in editorial board member in number of international journals. Dr. Malki presented many of his research findings as an invited speaker at multiple international conferences and professional meetings. Dr. Malki’s researches focus on the understanding of the signaling pathways that regulate cell proliferation, cell death and designing novel anticancer drugs targeting p53. Dr. Malki has more than 15 years of experiences in academia teaching undergraduate, graduate courses, supervising students and applied research. He supervised more than 20 master students in the field of molecular therapeutics.

Dr. Malki’s researches focus on the understanding of the signaling pathways that regulate cell proliferation, cell death and designing novel anticancer drugs targeting p53.